Report Detail

Request for Sample of this report

Pharma & Healthcare Global Radiopharmaceutical Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4653862
    • |
  • 05 December, 2025
    • |
  • Global
    • |
  • 117 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Radiopharmaceutical market size was valued at US$ 6871 million in 2024 and is forecast to a readjusted size of USD 11060 million by 2031 with a CAGR of 7.1% during review period.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The radiopharmaceutical market is driven primarily by the growing prevalence of cancer and cardiovascular diseases, which require precise diagnostic tools for early detection and treatment. The increasing adoption of nuclear medicine imaging techniques, such as PET and SPECT scans, has further fueled demand for radiopharmaceuticals. Additionally, technological advancements in radiopharmaceuticals, along with the development of new radioisotopes for more targeted therapies, are expanding the applications of these drugs, making them critical in personalized medicine.
Despite the promising growth, the radiopharmaceutical market faces significant challenges, including the high cost of production and the short half-life of many radioisotopes, which complicates distribution and storage. Regulatory hurdles are another barrier, as radiopharmaceuticals require stringent approval processes due to their radioactive nature. Moreover, limited availability of specialized infrastructure and the shortage of trained professionals in nuclear medicine also hinder widespread adoption, especially in developing regions.
There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions. In developed countries (a quarter of the world population) about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this.
Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs, or to treat disease. In most cases, the information is used by physicians to make a quick diagnosis of the patient's illness. The thyroid, bones, heart, liver, and many other organs can be easily imaged, and disorders in their function revealed. In some cases radiation can be used to treat diseased organs, or tumours.
Over 10,000 hospitals worldwide use radioisotopes in medicine, and about 90% of the procedures are for diagnosis. The most common radioisotope used in diagnosis is technetium-99 (Tc-99m) accounting for about 80% of all nuclear medicine procedures and 85% of diagnostic scans in nuclear medicine worldwide.Over 50 million nuclear medicine procedures are performed each year, and demand for radioisotopes is increasing.
This report is a detailed and comprehensive analysis for global Radiopharmaceutical market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Radiopharmaceutical market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (USD/Dose), 2020-2031
Global Radiopharmaceutical market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (USD/Dose), 2020-2031
Global Radiopharmaceutical market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (USD/Dose), 2020-2031
Global Radiopharmaceutical market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (USD/Dose), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Radiopharmaceutical
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Radiopharmaceutical market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cardinal Health, GE Healthcare, Jubilant Pharma, Novartis, Curium Pharma, SIEMENS, Lantheus, Bracco Imaging, Bayer, Eli Lilly, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Radiopharmaceutical market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Diagnostic Radiopharmaceuticals
Therapeutic Radiopharmaceuticals
Market segment by Application
Oncology
Cardiology
Other
Major players covered
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Dongcheng
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Radiopharmaceutical product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Radiopharmaceutical, with price, sales quantity, revenue, and global market share of Radiopharmaceutical from 2020 to 2025.
Chapter 3, the Radiopharmaceutical competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiopharmaceutical breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Radiopharmaceutical market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Radiopharmaceutical.
Chapter 14 and 15, to describe Radiopharmaceutical sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Radiopharmaceutical Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Diagnostic Radiopharmaceuticals
    • 1.3.3 Therapeutic Radiopharmaceuticals
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Radiopharmaceutical Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Oncology
    • 1.4.3 Cardiology
    • 1.4.4 Other
  • 1.5 Global Radiopharmaceutical Market Size & Forecast
    • 1.5.1 Global Radiopharmaceutical Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Radiopharmaceutical Sales Quantity (2020-2031)
    • 1.5.3 Global Radiopharmaceutical Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Cardinal Health
    • 2.1.1 Cardinal Health Details
    • 2.1.2 Cardinal Health Major Business
    • 2.1.3 Cardinal Health Radiopharmaceutical Product and Services
    • 2.1.4 Cardinal Health Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Cardinal Health Recent Developments/Updates
  • 2.2 GE Healthcare
    • 2.2.1 GE Healthcare Details
    • 2.2.2 GE Healthcare Major Business
    • 2.2.3 GE Healthcare Radiopharmaceutical Product and Services
    • 2.2.4 GE Healthcare Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 GE Healthcare Recent Developments/Updates
  • 2.3 Jubilant Pharma
    • 2.3.1 Jubilant Pharma Details
    • 2.3.2 Jubilant Pharma Major Business
    • 2.3.3 Jubilant Pharma Radiopharmaceutical Product and Services
    • 2.3.4 Jubilant Pharma Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Jubilant Pharma Recent Developments/Updates
  • 2.4 Novartis
    • 2.4.1 Novartis Details
    • 2.4.2 Novartis Major Business
    • 2.4.3 Novartis Radiopharmaceutical Product and Services
    • 2.4.4 Novartis Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Novartis Recent Developments/Updates
  • 2.5 Curium Pharma
    • 2.5.1 Curium Pharma Details
    • 2.5.2 Curium Pharma Major Business
    • 2.5.3 Curium Pharma Radiopharmaceutical Product and Services
    • 2.5.4 Curium Pharma Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Curium Pharma Recent Developments/Updates
  • 2.6 SIEMENS
    • 2.6.1 SIEMENS Details
    • 2.6.2 SIEMENS Major Business
    • 2.6.3 SIEMENS Radiopharmaceutical Product and Services
    • 2.6.4 SIEMENS Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 SIEMENS Recent Developments/Updates
  • 2.7 Lantheus
    • 2.7.1 Lantheus Details
    • 2.7.2 Lantheus Major Business
    • 2.7.3 Lantheus Radiopharmaceutical Product and Services
    • 2.7.4 Lantheus Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Lantheus Recent Developments/Updates
  • 2.8 Bracco Imaging
    • 2.8.1 Bracco Imaging Details
    • 2.8.2 Bracco Imaging Major Business
    • 2.8.3 Bracco Imaging Radiopharmaceutical Product and Services
    • 2.8.4 Bracco Imaging Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Bracco Imaging Recent Developments/Updates
  • 2.9 Bayer
    • 2.9.1 Bayer Details
    • 2.9.2 Bayer Major Business
    • 2.9.3 Bayer Radiopharmaceutical Product and Services
    • 2.9.4 Bayer Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Bayer Recent Developments/Updates
  • 2.10 Eli Lilly
    • 2.10.1 Eli Lilly Details
    • 2.10.2 Eli Lilly Major Business
    • 2.10.3 Eli Lilly Radiopharmaceutical Product and Services
    • 2.10.4 Eli Lilly Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Eli Lilly Recent Developments/Updates
  • 2.11 Aurobindo Pharma
    • 2.11.1 Aurobindo Pharma Details
    • 2.11.2 Aurobindo Pharma Major Business
    • 2.11.3 Aurobindo Pharma Radiopharmaceutical Product and Services
    • 2.11.4 Aurobindo Pharma Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Aurobindo Pharma Recent Developments/Updates
  • 2.12 Mundipharma
    • 2.12.1 Mundipharma Details
    • 2.12.2 Mundipharma Major Business
    • 2.12.3 Mundipharma Radiopharmaceutical Product and Services
    • 2.12.4 Mundipharma Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Mundipharma Recent Developments/Updates
  • 2.13 China Isotope & Radiation
    • 2.13.1 China Isotope & Radiation Details
    • 2.13.2 China Isotope & Radiation Major Business
    • 2.13.3 China Isotope & Radiation Radiopharmaceutical Product and Services
    • 2.13.4 China Isotope & Radiation Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 China Isotope & Radiation Recent Developments/Updates
  • 2.14 Dongcheng
    • 2.14.1 Dongcheng Details
    • 2.14.2 Dongcheng Major Business
    • 2.14.3 Dongcheng Radiopharmaceutical Product and Services
    • 2.14.4 Dongcheng Radiopharmaceutical Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Dongcheng Recent Developments/Updates

3 Competitive Environment: Radiopharmaceutical by Manufacturer

  • 3.1 Global Radiopharmaceutical Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Radiopharmaceutical Revenue by Manufacturer (2020-2025)
  • 3.3 Global Radiopharmaceutical Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Radiopharmaceutical by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Radiopharmaceutical Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Radiopharmaceutical Manufacturer Market Share in 2024
  • 3.5 Radiopharmaceutical Market: Overall Company Footprint Analysis
    • 3.5.1 Radiopharmaceutical Market: Region Footprint
    • 3.5.2 Radiopharmaceutical Market: Company Product Type Footprint
    • 3.5.3 Radiopharmaceutical Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Radiopharmaceutical Market Size by Region
    • 4.1.1 Global Radiopharmaceutical Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Radiopharmaceutical Consumption Value by Region (2020-2031)
    • 4.1.3 Global Radiopharmaceutical Average Price by Region (2020-2031)
  • 4.2 North America Radiopharmaceutical Consumption Value (2020-2031)
  • 4.3 Europe Radiopharmaceutical Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Radiopharmaceutical Consumption Value (2020-2031)
  • 4.5 South America Radiopharmaceutical Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Radiopharmaceutical Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Radiopharmaceutical Sales Quantity by Type (2020-2031)
  • 5.2 Global Radiopharmaceutical Consumption Value by Type (2020-2031)
  • 5.3 Global Radiopharmaceutical Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Radiopharmaceutical Sales Quantity by Application (2020-2031)
  • 6.2 Global Radiopharmaceutical Consumption Value by Application (2020-2031)
  • 6.3 Global Radiopharmaceutical Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Radiopharmaceutical Sales Quantity by Type (2020-2031)
  • 7.2 North America Radiopharmaceutical Sales Quantity by Application (2020-2031)
  • 7.3 North America Radiopharmaceutical Market Size by Country
    • 7.3.1 North America Radiopharmaceutical Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Radiopharmaceutical Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Radiopharmaceutical Sales Quantity by Type (2020-2031)
  • 8.2 Europe Radiopharmaceutical Sales Quantity by Application (2020-2031)
  • 8.3 Europe Radiopharmaceutical Market Size by Country
    • 8.3.1 Europe Radiopharmaceutical Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Radiopharmaceutical Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Radiopharmaceutical Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Radiopharmaceutical Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Radiopharmaceutical Market Size by Region
    • 9.3.1 Asia-Pacific Radiopharmaceutical Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Radiopharmaceutical Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Radiopharmaceutical Sales Quantity by Type (2020-2031)
  • 10.2 South America Radiopharmaceutical Sales Quantity by Application (2020-2031)
  • 10.3 South America Radiopharmaceutical Market Size by Country
    • 10.3.1 South America Radiopharmaceutical Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Radiopharmaceutical Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Radiopharmaceutical Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Radiopharmaceutical Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Radiopharmaceutical Market Size by Country
    • 11.3.1 Middle East & Africa Radiopharmaceutical Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Radiopharmaceutical Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Radiopharmaceutical Market Drivers
  • 12.2 Radiopharmaceutical Market Restraints
  • 12.3 Radiopharmaceutical Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Radiopharmaceutical and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Radiopharmaceutical
  • 13.3 Radiopharmaceutical Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Radiopharmaceutical Typical Distributors
  • 14.3 Radiopharmaceutical Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Radiopharmaceutical. Industry analysis & Market Report on Radiopharmaceutical is a syndicated market report, published as Global Radiopharmaceutical Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Radiopharmaceutical market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo